IRF1 and nonpapillary renal cell carcinoma: The observation that IFNγ signaling and IRF1 expression are important biomarkers in ccRCC (Kong et al., 2022), addressing the importance of the SPOP-IRF1 axis in this cancer type may be of particular interest in future studies.